stoxline Quote Chart Rank Option Currency Glossary
  
(BLFS)
  0 (0%)    02-21 15:55
Open:
High:
Volume: 0
  
Pre. Close:
Low:
Market Cap: 0(M)
Technical analysis
2026-02-20 4:44:00 PM
Short term     
Mid term     
Targets 6-month :  28.68 1-year :  30.99
Resists First :  24.55 Second :  26.54
Pivot price 22.46
Supports First :  21.35 Second :  17.76
MAs MA(5) :  22.75 MA(20) :  22.86
MA(100) :  25.3 MA(250) :  24.21
MACD MACD :  -0.5 Signal :  -0.6
%K %D K(14,3) :  67 D(3) :  49
RSI RSI(14): 48.6
52-week High :  29.62 Low :  19.1
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ BLFS ] has closed below upper band by 14.5%. Bollinger Bands are 46.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 23.72 - 23.84 23.84 - 23.92
Low: 22.52 - 22.67 22.67 - 22.77
Close: 22.86 - 23.1 23.1 - 23.25
Company Description

Headline News

Tue, 17 Feb 2026
BioLife Solutions, Inc. (BLFS): Analyst Consensus Signals 45.95% Potential Upside - DirectorsTalk Interviews

Tue, 17 Feb 2026
BioLife Solutions to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update on February 26, 2026 - Finviz

Sun, 15 Feb 2026
Flora Growth Corp. (FLGC) Announces Q3 Loss and Falls Short of Revenue Projections - Intellectia AI

Sun, 15 Feb 2026
Why BLFS stock attracts global investors - Portfolio Update Summary & Risk Controlled Swing Trade Alerts - mfd.ru

Thu, 12 Feb 2026
BioLife Solutions (BLFS) Secures Supply Deal with Qkine for Key CGT Products - GuruFocus

Thu, 12 Feb 2026
BioLife Solutions Signs Multi-Year Supply Agreement with Qkine Limited to Expand its Product Portfolio into the Rapidly Growing Cytokines Market - PR Newswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
Sector:
Industry:
Shares Out 48 (M)
Shares Float 41 (M)
Held by Insiders 1.7 (%)
Held by Institutions 106.2 (%)
Shares Short 2,830 (K)
Shares Short P.Month 2,780 (K)
Stock Financials
EPS -0.38
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 7.38
Profit Margin -3.3 %
Operating Margin -0.4 %
Return on Assets (ttm) -0.8 %
Return on Equity (ttm) -5.3 %
Qtrly Rev. Growth 31.2 %
Gross Profit (p.s.) 1.33
Sales Per Share 2.07
EBITDA (p.s.) -0.04
Qtrly Earnings Growth 0 %
Operating Cash Flow 17 (M)
Levered Free Cash Flow 28 (M)
Stock Valuations
PE Ratio -60.77
PEG Ratio 0
Price to Book value 3.12
Price to Sales 11.1
Price to Cash Flow 66.02
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android